[1]
J. C. Grotta et al., Stroke: Pathophysiology, Diagnosis, and Management, 6th ed. London: Elsevier Health Sciences, 2015. Available: http://www.sciencedirect.com/science/book/9780323295444
[2]
L. Pantoni and P. B. Gorelick, Eds, Cerebral small vessel disease, vol. Cambridge medicine. Cambridge: Cambridge University Press, 2014. Available: http://dx.doi.org/10.1017/CBO9781139382694
[3]
L. Pantoni, ‘Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges’, The Lancet Neurology, vol. 9, no. 7, pp. 689–701, July 2010, doi: 10.1016/S1474-4422(10)70104-6
[4]
A. A. Gouw et al., ‘Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations’, Journal of Neurology, Neurosurgery & Psychiatry, vol. 82, no. 2, pp. 126–135, Feb. 2011, doi: 10.1136/jnnp.2009.204685
[5]
S. Homma, ‘Patent Foramen Ovale and Stroke’, Circulation, vol. 112, no. 7, pp. 1063–1072, Aug. 2005, doi: 10.1161/CIRCULATIONAHA.104.524371
[6]
R. G. Hart et al., ‘Embolic strokes of undetermined source: the case for a new clinical construct’, The Lancet Neurology, vol. 13, no. 4, pp. 429–438, Apr. 2014, doi: 10.1016/S1474-4422(13)70310-7
[7]
‘Atrial fibrillation: the management of atrial fibrillation | Guidance and guidelines | NICE’, Available: https://www.nice.org.uk/guidance/cg180
[8]
P. A. Wolf, R. D. Abbott, and W. B. Kannel, ‘Atrial fibrillation as an independent risk factor for stroke: the Framingham Study’, Stroke, vol. 22, no. 8, pp. 983–988, Aug. 1991, doi: 10.1161/01.STR.22.8.983
[9]
R. Wakili, N. Voigt, S. Kääb, D. Dobrev, and S. Nattel, ‘Recent advances in the molecular pathophysiology of atrial fibrillation’, Journal of Clinical Investigation, vol. 121, no. 8, pp. 2955–2968, Aug. 2011, doi: 10.1172/JCI46315
[10]
L. A. Sposato, L. E. Cipriano, P. M. Riccio, V. Hachinski, and G. Saposnik, ‘Very short paroxysms account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis’, International Journal of Stroke, vol. 10, no. 6, pp. 801–807, Aug. 2015, doi: 10.1111/ijs.12555
[11]
J. M. Ferro, ‘Cardioembolic stroke: an update’, The Lancet Neurology, vol. 2, no. 3, pp. 177–188, Mar. 2003, doi: 10.1016/S1474-4422(03)00324-7
[12]
C. S. Anderson et al., ‘Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage’, New England Journal of Medicine, vol. 368, no. 25, pp. 2355–2365, June 2013, doi: 10.1056/NEJMoa1214609
[13]
L.-E. Bohman and J. M. Levine, ‘Fever and therapeutic normothermia in severe brain injury’, Current Opinion in Critical Care, vol. 20, no. 2, pp. 182–188, Apr. 2014, doi: 10.1097/MCC.0000000000000070
[14]
C. Delcourt and C. Anderson, ‘Acute intracerebral haemorrhage: Grounds for optimism in management’, Journal of Clinical Neuroscience, vol. 19, no. 12, pp. 1622–1626, Dec. 2012, doi: 10.1016/j.jocn.2012.05.018
[15]
Grise, Erin M., ‘Blood pressure control for acute ischemic and hemorrhagic stroke’, Current Opinion in Critical Care, vol. 18, no. 2, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00075198-201204000-00005&LSLINK=80&D=ovft
[16]
‘Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008’, Cerebrovascular Diseases, vol. 25, no. 5, pp. 457–507, 2008, doi: 10.1159/000131083
[17]
Flower, Oliver, ‘The acute management of intracerebral hemorrhage’, Current Opinion in Critical Care, vol. 17, no. 2, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00075198-201104000-00005&LSLINK=80&D=ovft
[18]
Gioia, Laura C.a, ‘Blood pressure management in acute intracerebral hemorrhage:  current evidence and ongoing controversies’, Current Opinion in Critical Care, vol. 21, no. 2, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00075198-201504000-00003&LSLINK=80&D=ovft
[19]
J. C. Hemphill et al., ‘Guidelines for the Management of Spontaneous Intracerebral Hemorrhage’, Stroke, vol. 46, no. 7, pp. 2032–2060, July 2015, doi: 10.1161/STR.0000000000000069
[20]
E. C. Jauch et al., ‘Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association’, Stroke, vol. 44, no. 3, pp. 870–947, Mar. 2013, doi: 10.1161/STR.0b013e318284056a
[21]
Kalanuria, Atul A.a , b, ‘Early prognostication in acute brain damage:  where is the evidence?’, Current Opinion in Critical Care, vol. 19, no. 2, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00075198-201304000-00008&LSLINK=80&D=ovft
[22]
M. A. Kirkman, G. Citerio, and M. Smith, ‘The intensive care management of acute ischemic stroke: an overview’, Intensive Care Medicine, vol. 40, no. 5, pp. 640–653, May 2014, doi: 10.1007/s00134-014-3266-z
[23]
Kirkman, Matthew A. MBBS*,†, ‘Supratentorial Intracerebral Hemorrhage:  A Review of the Underlying Pathophysiology and its Relevance for Multimodality Neuromonitoring in Neurointensive Care’, Journal of Neurosurgical Anesthesiology, vol. 25, no. 3, pp. 228–239, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00008506-201307000-00002&LSLINK=80&D=ovft
[24]
Smith, Martin MBBS, FRCA, ‘Monitoring Intracranial Pressure in Traumatic Brain Injury’, Anesthesia & Analgesia, vol. 106, no. 1, pp. 240–248, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00000539-200801000-00042&LSLINK=80&D=ovft
[25]
Wartenberg, Katja E., ‘Malignant middle cerebral artery infarction’, Current Opinion in Critical Care, vol. 18, no. 2, Available: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00075198-201204000-00008&LSLINK=80&D=ovft
[26]
J. C. Rose and S. A. Mayer, ‘Optimizing Blood Pressure in Neurological Emergencies’, Neurocritical Care, vol. 1, no. 3, pp. 287–300, 2004, doi: 10.1385/NCC:1:3:287
[27]
M. Oeinck et al., ‘Dynamic Cerebral Autoregulation in Acute Intracerebral Hemorrhage’, Stroke, vol. 44, no. 10, pp. 2722–2728, Oct. 2013, doi: 10.1161/STROKEAHA.113.001913
[28]
J. A. Staessen, J. Wang, G. Bianchi, and W. H. Birkenhäger, ‘Essential hypertension’, The Lancet, vol. 361, no. 9369, pp. 1629–1641, May 2003, doi: 10.1016/S0140-6736(03)13302-8
[29]
A. W. Cowley, ‘Long-term control of arterial blood pressure’, Physiological Reviews, vol. 72, no. 1, pp. 231–300, Jan. 1992, Available: http://physrev.physiology.org/content/72/1/231
[30]
N. J. Abbott, A. A. K. Patabendige, D. E. M. Dolman, S. R. Yusof, and D. J. Begley, ‘Structure and function of the blood–brain barrier’, Neurobiology of Disease, vol. 37, no. 1, pp. 13–25, Jan. 2010, doi: 10.1016/j.nbd.2009.07.030
[31]
L. R. Bridges et al., ‘Blood-Brain Barrier Dysfunction and Cerebral Small Vessel Disease (Arteriolosclerosis) in Brains of Older People’, Journal of Neuropathology & Experimental Neurology, vol. 73, no. 11, pp. 1026–1033, Nov. 2014, doi: 10.1097/NEN.0000000000000124
[32]
J. Y. W. Liu et al., ‘Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy’, Brain, vol. 135, no. 10, pp. 3115–3133, Oct. 2012, doi: 10.1093/brain/aws147
[33]
S. Taheri et al., ‘Blood-Brain Barrier Permeability Abnormalities in Vascular Cognitive Impairment’, Stroke, vol. 42, no. 8, pp. 2158–2163, Aug. 2011, doi: 10.1161/STROKEAHA.110.611731
[34]
J. M. Wardlaw, P. A. G. Sandercock, M. S. Dennis, J. Starr, and H. Kalimo, ‘Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?’, Stroke, vol. 34, no. 3, pp. 806–812, Mar. 2003, doi: 10.1161/01.STR.0000058480.77236.B3
[35]
Z. Zhao et al., ‘Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance’, Nature Neuroscience, vol. 18, no. 7, pp. 978–987, May 2015, doi: 10.1038/nn.4025
[36]
B. V. Zlokovic, ‘The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders’, Neuron, vol. 57, no. 2, pp. 178–201, Jan. 2008, doi: 10.1016/j.neuron.2008.01.003
[37]
B. V. Zlokovic, ‘Cerebrovascular Effects of Apolipoprotein E’, JAMA Neurology, vol. 70, no. 4, Apr. 2013, doi: 10.1001/jamaneurol.2013.2152
[38]
K. D. Hougaard et al., ‘Remote Ischemic Perconditioning as an Adjunct Therapy to Thrombolysis in Patients With Acute Ischemic Stroke: A Randomized Trial’, Stroke, vol. 45, no. 1, pp. 159–167, Jan. 2014, doi: 10.1161/STROKEAHA.113.001346
[39]
S. Grupke, J. Hall, M. Dobbs, G. J. Bix, and J. F. Fraser, ‘Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: From review to preview’, Clinical Neurology and Neurosurgery, vol. 129, pp. 1–9, Feb. 2015, doi: 10.1016/j.clineuro.2014.11.013
[40]
K. R. Lees, ‘Does neuroprotection improve stroke outcome?’, The Lancet, vol. 351, no. 9114, pp. 1447–1448, May 1998, doi: 10.1016/S0140-6736(05)78865-6
[41]
Y. Wang, C. Reis, R. Applegate, G. Stier, R. Martin, and J. H. Zhang, ‘Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke’, Experimental Neurology, Apr. 2015, doi: 10.1016/j.expneurol.2015.04.009
[42]
M. Habs et al., ‘Age determination of vessel wall hematoma in spontaneous cervical artery dissection: A multi-sequence 3T Cardiovascular Magnetic resonance study’, Journal of Cardiovascular Magnetic Resonance, vol. 13, no. 1, 2011, doi: 10.1186/1532-429X-13-76
[43]
A. Gupta et al., ‘Carotid Plaque MRI and Stroke Risk: A Systematic Review and Meta-analysis’, Stroke, vol. 44, no. 11, pp. 3071–3077, Nov. 2013, doi: 10.1161/STROKEAHA.113.002551
[44]
C. Yuan et al., ‘MRI of atherosclerosis in clinical trials’, NMR in Biomedicine, vol. 19, no. 6, pp. 636–654, Oct. 2006, doi: 10.1002/nbm.1065
[45]
N. Altaf, S. T. MacSweeney, J. Gladman, and D. P. Auer, ‘Carotid Intraplaque Hemorrhage Predicts Recurrent Symptoms in Patients With High-Grade Carotid Stenosis’, Stroke, vol. 38, no. 5, pp. 1633–1635, May 2007, doi: 10.1161/STROKEAHA.106.473066
[46]
N. Altaf et al., ‘Plaque Hemorrhage Is a Marker of Thromboembolic Activity in Patients with Symptomatic Carotid Disease’, Radiology, vol. 258, no. 2, pp. 538–545, Feb. 2011, doi: 10.1148/radiol.10100198
[47]
D. K. Jones, Diffusion MRI: theory, methods, and applications. New York: Oxford University Press, 2011.
[48]
P. B. Barker, X. Golay, and G. Zaharchuk, Clinical perfusion MRI techniques and applications. Cambridge: Cambridge University Press, 2013.
[49]
D. Wilson, M. E. Adams, F. Robertson, M. Murphy, and D. J. Werring, ‘Investigating intracerebral haemorrhage’, BMJ, vol. 350, no. may20 10, pp. h2484–h2484, May 2015, doi: 10.1136/bmj.h2484
[50]
D. Wilson, A. Charidimou, and D. J. Werring, ‘Advances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging’, Expert Review of Neurotherapeutics, vol. 14, no. 6, pp. 661–678, June 2014, doi: 10.1586/14737175.2014.918506
[51]
J. C. Hemphill et al., ‘Guidelines for the Management of Spontaneous Intracerebral Hemorrhage’, Stroke, vol. 46, no. 7, pp. 2032–2060, July 2015, doi: 10.1161/STR.0000000000000069
[52]
T. H. Murphy and D. Corbett, ‘Plasticity during stroke recovery: from synapse to behaviour’, Nature Reviews Neuroscience, vol. 10, no. 12, pp. 861–872, Dec. 2009, doi: 10.1038/nrn2735
[53]
S. R. Zeiler and J. W. Krakauer, ‘The interaction between training and plasticity in the poststroke brain’, Current Opinion in Neurology, vol. 26, no. 6, pp. 609–616, Dec. 2013, doi: 10.1097/WCO.0000000000000025
[54]
J. W. Krakauer, S. T. Carmichael, D. Corbett, and G. F. Wittenberg, ‘Getting Neurorehabilitation Right: What Can Be Learned From Animal Models?’, Neurorehabilitation and Neural Repair, vol. 26, no. 8, pp. 923–931, Oct. 2012, doi: 10.1177/1545968312440745
[55]
N. S. Ward, ‘Does neuroimaging help to deliver better recovery of movement after stroke?’, Current Opinion in Neurology, vol. 28, no. 4, pp. 323–329, Aug. 2015, doi: 10.1097/WCO.0000000000000223
[56]
N. S. Ward, ‘Using oscillations to understand recovery after stroke’, Brain, vol. 138, no. 10, pp. 2811–2813, Oct. 2015, doi: 10.1093/brain/awv265
[57]
J. Krakauer and R. Marshall, ‘The proportional recovery rule for stroke revisited’, Annals of Neurology, p. n/a-n/a, Oct. 2015, doi: 10.1002/ana.24537
[58]
F. Coupar, A. Pollock, P. Rowe, C. Weir, and P. Langhorne, ‘Predictors of upper limb recovery after stroke: a systematic review and meta-analysis’, Clinical Rehabilitation, vol. 26, no. 4, pp. 291–313, Apr. 2012, doi: 10.1177/0269215511420305
[59]
C. M. Stinear, P. A. Barber, M. Petoe, S. Anwar, and W. D. Byblow, ‘The PREP algorithm predicts potential for upper limb recovery after stroke’, Brain, vol. 135, no. 8, pp. 2527–2535, Aug. 2012, doi: 10.1093/brain/aws146
[60]
T. M. H. Hope, M. L. Seghier, A. P. Leff, and C. J. Price, ‘Predicting outcome and recovery after stroke with lesions extracted from MRI images’, NeuroImage: Clinical, vol. 2, pp. 424–433, 2013, doi: 10.1016/j.nicl.2013.03.005
[61]
A. N. Clarkson, B. S. Huang, S. E. MacIsaac, I. Mody, and S. T. Carmichael, ‘Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke’, Nature, vol. 468, no. 7321, pp. 305–309, Nov. 2010, doi: 10.1038/nature09511
[62]
S. D. Hall et al., ‘The role of GABAergic modulation in motor function related neuronal network activity’, NeuroImage, vol. 56, no. 3, pp. 1506–1510, June 2011, doi: 10.1016/j.neuroimage.2011.02.025
[63]
H. C. Stary et al., ‘A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association’, Circulation, vol. 92, no. 5, pp. 1355–1374, Sept. 1995, doi: 10.1161/01.CIR.92.5.1355
[64]
R. Virmani, F. D. Kolodgie, A. P. Burke, A. Farb, and S. M. Schwartz, ‘Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions’, Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 5, pp. 1262–1275, May 2000, doi: 10.1161/01.ATV.20.5.1262
[65]
A. M. Malek, ‘Hemodynamic Shear Stress and Its Role in Atherosclerosis’, JAMA, vol. 282, no. 21, Dec. 1999, doi: 10.1001/jama.282.21.2035
[66]
Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone, ‘Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling’, Journal of the American College of Cardiology, vol. 49, no. 25, pp. 2379–2393, June 2007, doi: 10.1016/j.jacc.2007.02.059
[67]
P. Libby, ‘Inflammation in atherosclerosis’, Nature, vol. 420, no. 6917, pp. 868–874, Dec. 2002, doi: 10.1038/nature01323
[68]
J. Astrup, L. Symon, N. M. Branston, and N. A. Lassen, ‘Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia’, Stroke, vol. 8, no. 1, pp. 51–57, Jan. 1977, doi: 10.1161/01.STR.8.1.51
[69]
F. R. Sharp, A. Lu, Y. Tang, and D. E. Millhorn, ‘Multiple Molecular Penumbras After Focal Cerebral Ischemia’, Journal of Cerebral Blood Flow and Metabolism, pp. 1011–1032, July 2000, doi: 10.1097/00004647-200007000-00001
[70]
M. D. Ginsberg, ‘Adventures in the Pathophysiology of Brain Ischemia: Penumbra, Gene Expression, Neuroprotection: The 2002 Thomas Willis Lecture’, Stroke, vol. 34, no. 1, pp. 214–223, Jan. 2003, doi: 10.1161/01.STR.0000048846.09677.62
[71]
M. Furlan, G. Marchal, J.-M. Derlon, J.-C. Baron, and F. Viader, ‘Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra’, Annals of Neurology, vol. 40, no. 2, pp. 216–226, Aug. 1996, doi: 10.1002/ana.410400213
[72]
P. Ramos-Cabrer, F. Campos, T. Sobrino, and J. Castillo, ‘Targeting the Ischemic Penumbra’, Stroke, vol. 42, no. 1, Supplement 1, pp. S7–S11, Jan. 2011, doi: 10.1161/STROKEAHA.110.596684
[73]
E. H. Lo, ‘A new penumbra: transitioning from injury into repair after stroke’, Nature Medicine, vol. 14, no. 5, pp. 497–500, May 2008, doi: 10.1038/nm1735
[74]
F. R. Sharp, A. Lu, Y. Tang, and D. E. Millhorn, ‘Multiple Molecular Penumbras After Focal Cerebral Ischemia’, Journal of Cerebral Blood Flow and Metabolism, pp. 1011–1032, July 2000, doi: 10.1097/00004647-200007000-00001
[75]
J. Lok et al., ‘Cell–cell Signaling in the Neurovascular Unit’, Neurochemical Research, vol. 32, no. 12, pp. 2032–2045, Dec. 2007, doi: 10.1007/s11064-007-9342-9
[76]
G. J. del Zoppo and J. M. Hallenbeck, ‘Advances in the Vascular Pathophysiology of Ischemic Stroke’, Thrombosis Research, vol. 98, no. 3, pp. 73–81, May 2000, doi: 10.1016/S0049-3848(00)00218-8
[77]
T P Obrenovitch, ‘The ischaemic penumbra: Twenty years on’, Cerebrovascular and brain metabolism reviews, vol. 7, no. 4, 1995.
[78]
J. J. Harris, R. Jolivet, and D. Attwell, ‘Synaptic Energy Use and Supply’, Neuron, vol. 75, no. 5, pp. 762–777, Sept. 2012, doi: 10.1016/j.neuron.2012.08.019
[79]
D. Attwell, A. M. Buchan, S. Charpak, M. Lauritzen, B. A. MacVicar, and E. A. Newman, ‘Glial and neuronal control of brain blood flow’, Nature, vol. 468, no. 7321, pp. 232–243, Nov. 2010, doi: 10.1038/nature09613
[80]
E. H. Lo, T. Dalkara, and M. A. Moskowitz, ‘Neurological diseases: Mechanisms, challenges and opportunities in stroke’, Nature Reviews Neuroscience, vol. 4, no. 5, pp. 399–414, May 2003, doi: 10.1038/nrn1106
[81]
C. Culmsee and J. Krieglstein, ‘Ischaemic brain damage after stroke: new insights into efficient therapeutic strategies. International Symposium on Neurodegeneration and Neuroprotection’, EMBO reports, vol. 8, no. 2, pp. 129–133, Feb. 2007, doi: 10.1038/sj.embor.7400892
[82]
C. N. Hall et al., ‘Capillary pericytes regulate cerebral blood flow in health and disease’, Nature, vol. 508, no. 7494, pp. 55–60, Mar. 2014, doi: 10.1038/nature13165
[83]
A. Fisch, Neuroanatomy: draw it to know it, 2nd ed. New York: Oxford University Press, 2012. Available: http://dx.doi.org/10.1093/med/9780199845712.001.0001
[84]
T A Yousry, ‘Localization of the motor hand area to a knob on the precentral gyrus. A new landmark.’, Brain, vol. 120, no. 1, pp. 141–157, 1997, Available: http://brain.oxfordjournals.org/content/120/1/141